{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:30:29Z","timestamp":1740148229910,"version":"3.37.3"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T00:00:00Z","timestamp":1635465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T00:00:00Z","timestamp":1635465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"health commission of zhejiang province","award":["2018KY577"],"award-info":[{"award-number":["2018KY577"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s12094-021-02711-9","type":"journal-article","created":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T17:02:50Z","timestamp":1635526970000},"page":"540-545","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Linezolid-induced thrombocytopenia in patients with acute myeloid leukemia: a matched case\u2013control study"],"prefix":"10.1007","volume":"24","author":[{"given":"Can","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingdi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6763-0822","authenticated-orcid":false,"given":"Shenxian","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,29]]},"reference":[{"key":"2711_CR1","doi-asserted-by":"publisher","first-page":"3547","DOI":"10.1182\/blood-2007-06-095844","volume":"110","author":"E Atallah","year":"2007","unstructured":"Atallah E, Cortes J, O\u2019Brien S, et al. Establishment of baseline toxicity expectations with standard frontline chemotherapy in acute myelogenous leukemia. Blood. 2007;110:3547\u201351.","journal-title":"Blood"},{"key":"2711_CR2","first-page":"1705","volume":"109","author":"H Kantarjian","year":"2007","unstructured":"Kantarjian H, Giles F, List A, et al. The incidence and impact of thrombocytopenia in myelodysplastic syndromes. Cancer-Am Cancer Soc. 2007;109:1705\u201314.","journal-title":"Cancer-Am Cancer Soc"},{"key":"2711_CR3","first-page":"1710","volume":"88","author":"VM Aquino","year":"2000","unstructured":"Aquino VM, Herrera L, Sandler ES, Buchanan GR. Feasibility of oral ciprofloxacin for the outpatient management of febrile neutropenia in selected children with cancer. Cancer-Am Cancer Soc. 2000;88:1710\u20134.","journal-title":"Cancer-Am Cancer Soc"},{"key":"2711_CR4","doi-asserted-by":"publisher","first-page":"882","DOI":"10.6004\/jnccn.2016.0093","volume":"14","author":"LR Baden","year":"2016","unstructured":"Baden LR, Swaminathan S, Angarone M, et al. Prevention and treatment of cancer-related infections, version 2.2016, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2016;14:882\u2013913.","journal-title":"J Natl Compr Canc Netw"},{"key":"2711_CR5","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1093\/cid\/cir073","volume":"52","author":"AG Freifeld","year":"2011","unstructured":"Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis. 2011;52:e56-93.","journal-title":"Clin Infect Dis"},{"key":"2711_CR6","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1086\/379327","volume":"37","author":"SA Nasraway","year":"2003","unstructured":"Nasraway SA, Shorr AF, Kuter DJ, O\u2019Grady N, Le VH, Cammarata SK. Linezolid does not increase the risk of thrombocytopenia in patients with nosocomial pneumonia: comparative analysis of linezolid and vancomycin use. Clin Infect Dis. 2003;37:1609\u201316.","journal-title":"Clin Infect Dis"},{"key":"2711_CR7","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1345\/aph.1C361","volume":"37","author":"WB Bernstein","year":"2003","unstructured":"Bernstein WB, Trotta RF, Rector JT, Tjaden JA, Barile AJ. Mechanisms for linezolid-induced anemia and thrombocytopenia. Ann Pharmacother. 2003;37:517\u201320.","journal-title":"Ann Pharmacother"},{"key":"2711_CR8","doi-asserted-by":"publisher","first-page":"e122","DOI":"10.1016\/S2352-3026(18)30231-X","volume":"6","author":"N Frey","year":"2019","unstructured":"Frey N, Jang JH, Szer J, et al. Eltrombopag treatment during induction chemotherapy for acute myeloid leukaemia: a randomised, double-blind, phase 2 study. Lancet Haematol. 2019;6:e122\u201331.","journal-title":"Lancet Haematol"},{"key":"2711_CR9","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1093\/jac\/dkg262","volume":"51","author":"D Honeybourne","year":"2003","unstructured":"Honeybourne D, Tobin C, Jevons G, Andrews J, Wise R. Intrapulmonary penetration of linezolid. J Antimicrob Chemother. 2003;51:1431\u20134.","journal-title":"J Antimicrob Chemother"},{"key":"2711_CR10","doi-asserted-by":"publisher","first-page":"757","DOI":"10.3109\/00365548.2011.585177","volume":"43","author":"OR Sipahi","year":"2011","unstructured":"Sipahi OR, Bardak S, Turhan T, et al. Linezolid in the treatment of methicillin-resistant staphylococcal post-neurosurgical meningitis: a series of 17 cases. Scand J Infect Dis. 2011;43:757\u201364.","journal-title":"Scand J Infect Dis"},{"key":"2711_CR11","doi-asserted-by":"publisher","first-page":"556","DOI":"10.3109\/00365548.2011.564649","volume":"43","author":"P Kjollerstrom","year":"2011","unstructured":"Kjollerstrom P, Brito MJ, Gouveia C, Ferreira G, Varandas L. Linezolid in the treatment of multidrug-resistant\/extensively drug-resistant tuberculosis in paediatric patients: experience of a paediatric infectious diseases unit. Scand J Infect Dis. 2011;43:556\u20139.","journal-title":"Scand J Infect Dis"},{"key":"2711_CR12","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/s11096-014-9961-6","volume":"36","author":"R Hirano","year":"2014","unstructured":"Hirano R, Sakamoto Y, Tachibana N, Ohnishi M. Retrospective analysis of the risk factors for linezolid-induced thrombocytopenia in adult Japanese patients. Int J Clin Pharm-Net. 2014;36:795\u20139.","journal-title":"Int J Clin Pharm-Net"},{"key":"2711_CR13","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1016\/j.clinthera.2009.10.017","volume":"31","author":"T Niwa","year":"2009","unstructured":"Niwa T, Suzuki A, Sakakibara S, et al. Retrospective cohort chart review study of factors associated with the development of thrombocytopenia in adult Japanese patients who received intravenous linezolid therapy. Clin Ther. 2009;31:2126\u201333.","journal-title":"Clin Ther"},{"key":"2711_CR14","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1007\/s10156-010-0182-1","volume":"17","author":"Y Takahashi","year":"2011","unstructured":"Takahashi Y, Takesue Y, Nakajima K, et al. Risk factors associated with the development of thrombocytopenia in patients who received linezolid therapy. J Infect Chemother. 2011;17:382\u20137.","journal-title":"J Infect Chemother"},{"key":"2711_CR15","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/s11096-014-9961-6","volume":"36","author":"R Hirano","year":"2014","unstructured":"Hirano R, Sakamoto Y, Tachibana N, Ohnishi M. Retrospective analysis of the risk factors for linezolid-induced thrombocytopenia in adult Japanese patients. Int J Clin Pharm. 2014;36:795\u20139.","journal-title":"Int J Clin Pharm"},{"issue":"4","key":"2711_CR16","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1111\/jcpt.13159","volume":"45","author":"D Zhou","year":"2020","unstructured":"Zhou D, Shi T, Zhao S, Zhu J, Zhu L, Yang X, Xie W, Ye X. Linezolid is safe on platelet count for AML patients during myelosuppression after consolidation chemotherapy. J Clin Pharm Ther. 2020;45(4):755\u20138.","journal-title":"J Clin Pharm Ther"},{"key":"2711_CR17","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1002\/phar.1824","volume":"36","author":"AN Nedved","year":"2016","unstructured":"Nedved AN, DeFrates SR, Hladnik LM, Stockerl-Goldstein KE. Effect of linezolid on hematologic recovery in newly diagnosed acute myeloid leukemia patients following induction chemotherapy. Pharmacotherapy. 2016;36:1087\u201394.","journal-title":"Pharmacotherapy"},{"key":"2711_CR18","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.jiac.2015.06.007","volume":"21","author":"H Kato","year":"2015","unstructured":"Kato H, Hamada Y, Hagihara M, et al. Bicytopenia, especially thrombocytopenia in hemodialysis and non-hemodialysis patients treated with linezolid therapy. J Infect Chemother. 2015;21:707\u201312.","journal-title":"J Infect Chemother"},{"key":"2711_CR19","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ijantimicag.2008.07.002","volume":"33","author":"K Matsumoto","year":"2009","unstructured":"Matsumoto K, Takeda Y, Takeshita A, et al. Renal function as a predictor of linezolid-induced thrombocytopenia. Int J Antimicrob Agents. 2009;33:98\u20139.","journal-title":"Int J Antimicrob Agents"},{"key":"2711_CR20","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.ijantimicag.2006.04.017","volume":"28","author":"YH Lin","year":"2006","unstructured":"Lin YH, Wu VC, Tsai IJ, et al. High frequency of linezolid-associated thrombocytopenia among patients with renal insufficiency. Int J Antimicrob Agents. 2006;28:345\u201351.","journal-title":"Int J Antimicrob Agents"},{"key":"2711_CR21","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.1128\/AAC.47.9.2775-2780.2003","volume":"47","author":"ME Brier","year":"2003","unstructured":"Brier ME, Stalker DJ, Aronoff GR, et al. Pharmacokinetics of linezolid in subjects with renal dysfunction. Antimicrob Agents Chemother. 2003;47:2775\u201380.","journal-title":"Antimicrob Agents Chemother"},{"key":"2711_CR22","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3109\/00365548.2011.608712","volume":"44","author":"Y Hiraki","year":"2012","unstructured":"Hiraki Y, Tsuji Y, Hiraike M, et al. Correlation between serum linezolid concentration and the development of thrombocytopenia. Scand J Infect Dis. 2012;44:60\u20134.","journal-title":"Scand J Infect Dis"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-021-02711-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-021-02711-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-021-02711-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T16:06:06Z","timestamp":1646064366000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-021-02711-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,29]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["2711"],"URL":"https:\/\/doi.org\/10.1007\/s12094-021-02711-9","relation":{},"ISSN":["1699-048X","1699-3055"],"issn-type":[{"type":"print","value":"1699-048X"},{"type":"electronic","value":"1699-3055"}],"subject":[],"published":{"date-parts":[[2021,10,29]]},"assertion":[{"value":"21 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by Ethical Committee of Affiliated Hangzhou First People\u2019s Hospital, Zhejiang University School of Medicine and conducted in accordance with the ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Subjects signed the informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}